FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

Transcatheter Septal Occluder

PMA: P050006 · Supplement: S117 · Decision Feb 20, 2026
Classifications
1
FEI Numbers
0
Registration Numbers
0

Research PMA P050006 in seconds

The Research Assistant summarizes PMA approval history, supplements and related safety signals — and cites every record.

Free to try · every answer cites its records

Basic Information

Device Name
Transcatheter Septal Occluder
Trade Name
GORE® CARDIOFORM ASD Occluder; GORE® CARDIOFORM Septal Occluder
PMA Number
P050006
Supplement Number
S117
Device Class
FDA Class 3
Product Code
MLV
Generic Name
Transcatheter septal occluder
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
30-Day Notice Accepted
Decision Code
OK30
Decision Date
February 20, 2026
Date Received
February 6, 2026
Supplement Type
30-Day Notice
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

to update the inspection method for the guidewire slot feature for both the GORE® CARDIOFORM ASD Occluder and GORE® CARDIOFORM Septal Occluder

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
MLV Transcatheter Septal Occluder